Proposal of a new PAF pharmacophoric map by the AM1 method

被引:1
作者
Rodriguez, CR
de Alencastro, RB
Barreiro, EJ
Fraga, CAM
机构
[1] Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, LASSBio, BR-21944970 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Quim, Dept Quim Organ, Grp Fisicoquim Organ,CT Lab, BR-21949000 Rio De Janeiro, Brazil
关键词
AM1; method; 3D pharmacophoric map; PAF receptor antagonists;
D O I
10.1016/S0928-0987(99)00029-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PAF is a powerful phospholipid-derived autacoid involved in many pathophysiological processes. Many PAF antagonists have been synthesized and assayed for therapeutic purposes. We have synthesized derivatives (5-7), structurally related to WEB 2086 (1), which were rationally designed based on a planar PAF receptor model previously described by Bures et al. (1994; J. Chem. Inf. Comput. Sci. 24, 218-223). However, pharmacological studies revealed that derivatives (5-7) were inactive as PAF antagonists. AMI quantum calculations of classical PAF antagonists (1-4), as well as of our derivatives (5-7), demonstrated that electronic features alone are unable to explain the lack of the activity of (5-7). These results induced us to propose a new tridimensional PAF receptor pharmacophoric map by analyzing all stable conformations obtained for derivatives (1-4). The interpoint distances (D1-D5) revealed that the lowest-energy conformers of (5-7) had similar geometries to derivatives (1-4). So, these aspects could not explain the inactivity of the compounds (6-7). The proposed model suggests that the best fit of antagonist compounds may involve the participation of a sulfur atom electron lone pair adequately oriented in relation to the plane of a N-aromatic ring present in the compounds investigated. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 24 条
[1]  
ALBUQUERQUE MG, 1995, INT J QUANTUM CHEM Q, V22, P181
[2]  
Alkorta I, 1996, INT J QUANTUM CHEM, V57, P123, DOI 10.1002/(SICI)1097-461X(1996)57:1<123::AID-QUA14>3.0.CO
[3]  
2-9
[4]  
AYSCOUGH A, 1995, EXPERT OPIN THER PAT, V5, P653
[5]   LEUKOCYTE-DEPENDENT HISTAMINE-RELEASE FROM RABBIT PLATELETS - ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR [J].
BENVENISTE, J ;
HENSON, PM ;
COCHRANE, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) :1356-+
[6]   PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS [J].
BRAQUET, P ;
GODFROID, JJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) :397-403
[7]   NEW MOLECULAR MODELING TOOLS USING 3-DIMENSIONAL CHEMICAL SUBSTRUCTURES [J].
BURES, MG ;
DANAHER, E ;
DELAZZER, J ;
MARTIN, YC .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1994, 34 (01) :218-223
[8]  
CAMPBELL WB, 1996, PHARMACOL BASIS THER, P611
[9]  
CARVALHO AS, 1996, J HETEROCYCLIC CHEM, V33, P309
[10]  
CARVALHO AS, 1996, J BRAZIL CHEM SOC, V7, P247